Please assess the completion status of the following clinical trial:

Trial Title: Bilateral Transversus Abdominis Plane Block With Exparel Verus Continuous Epidural Analgesia With Bupivacaine

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Written informed consent~* 18-85 years old~* ASA Physical Status 1-3~* Scheduled for elective open or laparoscopic abdominal surgery, including colorectal and hysterectomy surgeries~* Anticipated hospitalization of three nights~* Expected requirement for parenteral opioids for at least 72 hours for postoperative pain~* Able to use IV PCA systems.~Exclusion Criteria:~* Hepatic disease, e.g. twice the normal levels of liver enzymes~* Kidney disease, e.g. twice the normal level of serum creatinine~* Bupivacaine sensitivity or known allergy~* Women who are pregnant or breastfeeding~* Anticoagulants considered to be a contraindication for epidural or TAP blocks.~* Surgeries with high port sites will be excluded

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- TAP block with Exparel (Type: EXPERIMENTAL): Bilateral Transversus Abdominis Plane (TAP) block procedure following injection of liposomal bupivacaine (Exparel)
- Epidural analgesia with Bupivacaine (Type: ACTIVE_COMPARATOR): Epidural catheters with an infusion of Bupivacaine standard solution without additives

Based on this trial design, predict the completion outcome and termination type (if applicable).